HHS issues fraud alert concerning Dx lab payments to referring physicians; CardioDx wins Aetna coverage for CAD test;

> The Office of Inspector General of the U.S. Department of Health and Human Services has issued a fraud alert regarding how laboratory payments are made to referring physicians. Alert (PDF)

> Sophia Genetics raised $13.75 million in Series B financing designed to boost European adoption of clinical analytics for genetic diseases. Release

> CardioDx, a molecular diagnostics company, has obtained health insurance coverage approvals for its obstructive coronary artery disease test from both Aetna and Coventry Health. Release

> Five Senate Democrats want the White House to release for public comment a long-delayed FDA draft guidance on laboratory developed tests. Story

> Researchers at the Texas A&M Health Science Center College of Medicine, Stanford University and elsewhere have developed a promising new tuberculosis test that is quicker and costs little to use. Item

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.